GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Insider Ownership

Labiana Health (XMAD:LAB) Insider Ownership : 0.00 % (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Labiana Health's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Labiana Health's Institutional Ownership is 0.03%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Labiana Health's Float Percentage Of Total Shares Outstanding is 0.00%.


Labiana Health Insider Ownership Historical Data

The historical data trend for Labiana Health's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Insider Ownership Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Insider Ownership
- - -

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Insider Ownership - - - -

Labiana Health Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.